MHRA: Informal agreement on clinical trials regulation

Under the current Directive, the number of clinical trials declined and although this cannot be attributed to the Directive only, the Directive did fail to harmonise requirements across the EU. The MHRA believes that the Regulation has the potential to help make the EU a more attractive place for conducting clinical research.